Toshio Ohashi

Dr. Toshio Ohashi

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ATAtsuya Takeda
Atsuya Takeda
EKEtsuo Kunieda
Etsuo Kunieda
TOToshio Ohashi
Toshio Ohashi
YAYousuke Aoki
Yousuke Aoki
NKNaoyoshi Koike
Naoyoshi Koike
TTToshiaki Takeda
Toshiaki Takeda

1 February 2009 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
ATAtsuya Takeda
Atsuya Takeda
NSNaoko Sanuki
Naoko Sanuki
EKEtsuo Kunieda
Etsuo Kunieda
TOToshio Ohashi
Toshio Ohashi
YOYohei Oku
Yohei Oku
AKAtsushi Kubo
Atsushi Kubo

1 November 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ATAtsuya Takeda
Atsuya Takeda
NYNoriko Yokosuka
Noriko Yokosuka
TOToshio Ohashi
Toshio Ohashi
EKEtsuo Kunieda
Etsuo Kunieda
HFHirofumi Fujii
Hirofumi Fujii
YOYukihiko Ozawa
Yukihiko Ozawa

1 April 2012 in Chest
Verified
Journal Article
Closed access
PDF file
ATAtsuya Takeda
Atsuya Takeda
EKEtsuo Kunieda
Etsuo Kunieda
TOToshio Ohashi
Toshio Ohashi
YAYousuke Aoki
Yousuke Aoki
YOYohei Oku
Yohei Oku
MSMadoka Sugiura
Madoka Sugiura

1 May 2004 in American Journal of Roentgenology
Verified
Journal Article
Closed access
TTToshiaki Takeda
Toshiaki Takeda
ATAtsuya Takeda
Atsuya Takeda
EKEtsuo Kunieda
Etsuo Kunieda
AIAkitoshi Ishizaka
Akitoshi Ishizaka
KTKazuhiko Takemasa
Kazuhiko Takemasa
AKAtsushi Kubo
Atsushi Kubo
OBJECTIVE. We studied the serial changes and CT manifestations of pulmonary radiation injury after hypofractionated stereotactic radiation therapy for peripheral small lung tumors.SUBJECTS AND METHODS. Hypofractionated stereotactic radiation therapy was applied to 20 patients with proven primary (n = 11) or metastatic (n = 9) lung cancer, for a total of 22 lesions of 3 cm or less in diameter located within 3 cm from the parietal pleural surface. Follow-up CT was scheduled at 1 and 3 months, and every 3 months thereafter.RESULTS. Ground-glass opacities were observed around four (18%) of 22 lesions at 3–6 months. The opacities nearly corresponded to the planned target volume, but half of them were unevenly distributed. Ground-glass opacities gradually disappeared or evolved into dense consolidation while shrinking. Dense consolidations developed in 16 (73%) of 22 lesions, including seven in the center of the planned target volume and nine in the periphery of the planned target volume. Dense consolidations m...

1 March 2013 in Lung Cancer
Verified
Journal Article
Closed access
ATAtsuya Takeda
Atsuya Takeda
EKEtsuo Kunieda
Etsuo Kunieda
HFHirofumi Fujii
Hirofumi Fujii
NYNoriko Yokosuka
Noriko Yokosuka
YAYousuke Aoki
Yousuke Aoki
YOYukihiko Ozawa
Yukihiko Ozawa